CERo Therapeutics Holdings, Inc. (NASDAQ: CERO)
$0.0530
-0.0031 ( -8.46% ) 12.9M
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.
Market Data
Open
$0.0530
Previous close
$0.0561
Volume
12.9M
Market cap
$7.95M
Day range
$0.0520 - $0.0593
52 week range
$0.0467 - $12.3800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
pre | Proxies and info statements | 4 | Apr 03, 2024 |
8-k/a | 8K-related | 17 | Apr 02, 2024 |
nt | Quarterly Reports | 1 | Apr 02, 2024 |
10-k | Annual reports | 77 | Apr 02, 2024 |
4 | Insider transactions | 1 | Mar 27, 2024 |
4 | Insider transactions | 1 | Mar 27, 2024 |
4 | Insider transactions | 1 | Mar 27, 2024 |
4 | Insider transactions | 1 | Mar 27, 2024 |
4 | Insider transactions | 1 | Mar 27, 2024 |
4 | Insider transactions | 1 | Mar 27, 2024 |